Treatment and outcome of patients with metastatic NSCLC: a retrospective institution analysis of 493 patients

por Reinmuth, Niels, Payer, Nadine, Muley, Thomas, Hoffmann, Hans, Herth, Felix JF, Villalobos, Matthias, Thomas, Michael
Publicado 2013

Differential diagnostic value of CD5 and CD117 expression in thoracic tumors: A large scale study of 1465 non-small cell lung cancer cases

por Kriegsmann, Mark, Muley, Thomas, Harms, Alexander, Tavernar, Luca, Goldmann, Torsten, Dienemann, Hendrik, Herpel, Esther, Warth, Arne
Publicado 2015

Iron accumulation in tumor-associated macrophages marks an improved overall survival in patients with lung adenocarcinoma

por Thielmann, Carl Maximilian, Costa da Silva, Milene, Muley, Thomas, Meister, Michael, Herpel, Esther, Muckenthaler, Martina U.
Publicado 2019

Circulating Interleukin-4 Is Associated with a Systemic T Cell Response against Tumor-Associated Antigens in Treatment-Naïve Patients with Resectable Non-Small-Cell Lung Cancer

por Safi, Seyer, Yamauchi, Yoshikane, Hoffmann, Hans, Weichert, Wilko, Jost, Philipp J., Winter, Hauke, Muley, Thomas, Beckhove, Philipp
Publicado 2020

Low Input Whole-Exome Sequencing to Determine the Representation of the Tumor Exome in Circulating DNA of Non-Small Cell Lung Cancer Patients

por Dietz, Steffen, Schirmer, Uwe, Mercé, Clémentine, von Bubnoff, Nikolas, Dahl, Edgar, Meister, Michael, Muley, Thomas, Thomas, Michael, Sültmann, Holger
Publicado 2016

Mutation analysis of circulating plasma DNA to determine response to EGFR tyrosine kinase inhibitor therapy of lung adenocarcinoma patients

por Riediger, Anja Lisa, Dietz, Steffen, Schirmer, Uwe, Meister, Michael, Heinzmann-Groth, Ingrid, Schneider, Marc, Muley, Thomas, Thomas, Michael, Sültmann, Holger
Publicado 2016

Glycodelin is a potential novel follow-up biomarker for malignant pleural mesothelioma

por Schneider, Marc A., Muley, Thomas, Kahn, Nicolas C., Warth, Arne, Thomas, Michael, Herth, Felix J.F., Dienemann, Hendrik, Meister, Michael
Publicado 2016

Prognostic Impact of PD-L1 Expression in pN1 NSCLC: A Retrospective Single-Center Analysis

por Eichhorn, Florian, Kriegsmann, Mark, Klotz, Laura V., Kriegsmann, Katharina, Muley, Thomas, Zgorzelski, Christiane, Christopoulos, Petros, Winter, Hauke, Eichhorn, Martin E.
Publicado 2021

Corrigendum: Deep learning for the detection of anatomical tissue structures and neoplasms of the skin on scanned histopathological tissue sections

por Kriegsmann, Katharina, Lobers, Frithjof, Zgorzelski, Christiane, Kriegsmann, Jörg, Janßen, Charlotte, Meliß, Rolf Rüdinger, Muley, Thomas, Sack, Ulrich, Steinbuss, Georg, Kriegsmann, Mark
Publicado 2023

Pathways regulating the expression of the immunomodulatory protein glycodelin in non-small cell lung cancer

por Weber, Rebecca, Meister, Michael, Muley, Thomas, Thomas, Michael, Sültmann, Holger, Warth, Arne, Winter, Hauke, Herth, Felix J.F., Schneider, Marc A.
Publicado 2018

Validation of the T Descriptor (TNM-8) in T3N0 Non-Small-Cell Lung Cancer Patients; a Bicentric Cohort Analysis with Arguments for Redefinition

por Baum, Philip, Taber, Samantha, Erdmann, Stella, Muley, Thomas, Kriegsmann, Mark, Christopoulos, Petros, Thomas, Michael, Winter, Hauke, Pfannschmidt, Joachim, Eichhorn, Martin E.
Publicado 2021

Deep learning for the detection of anatomical tissue structures and neoplasms of the skin on scanned histopathological tissue sections

por Kriegsmann, Katharina, Lobers, Frithjof, Zgorzelski, Christiane, Kriegsmann, Jörg, Janßen, Charlotte, Meliß, Rolf Rüdinger, Muley, Thomas, Sack, Ulrich, Steinbuss, Georg, Kriegsmann, Mark
Publicado 2022

Development and Validation of a Risk Score for Predicting Death after Pneumonectomy

por Safi, Seyer, Benner, Axel, Walloschek, Janos, Renner, Maria, op den Winkel, Jan, Muley, Thomas, Storz, Konstantina, Dienemann, Hendrik, Hoffmann, Hans, Schneider, Thomas
Publicado 2015

Prevalence of somatic mitochondrial mutations and spatial distribution of mitochondria in non-small cell lung cancer

por Kazdal, Daniel, Harms, Alexander, Endris, Volker, Penzel, Roland, Kriegsmann, Mark, Eichhorn, Florian, Muley, Thomas, Stenzinger, Albrecht, Pfarr, Nicole, Weichert, Wilko, Warth, Arne
Publicado 2017

Expression of HMB45, MelanA and SOX10 is rare in non-small cell lung cancer

por Kriegsmann, Mark, Kriegsmann, Katharina, Harms, Alexander, Longuespée, Rémi, Zgorzelski, Christiane, Leichsenring, Jonas, Muley, Thomas, Winter, Hauke, Kazdal, Daniel, Goeppert, Benjamin, Warth, Arne
Publicado 2018

Acute Phase Proteins as Early Predictors for Immunotherapy Response in Advanced NSCLC: An Explorative Study

por Schneider, Marc A., Rozy, Adriana, Wrenger, Sabine, Christopoulos, Petros, Muley, Thomas, Thomas, Michael, Meister, Michael, Welte, Tobias, Chorostowska-Wynimko, Joanna, Janciauskiene, Sabina
Publicado 2022

Transmembrane serine protease 2 is a prognostic factor for lung adenocarcinoma

por Schneider, Marc A., Richtmann, Sarah, Gründing, Anna R., Wrenger, Sabine, Welte, Tobias, Meister, Michael, Kriegsmann, Mark, Winter, Hauke, Muley, Thomas, Janciauskiene, Sabina
Publicado 2022

Loss of aquaporin-4 expression and putative function in non-small cell lung cancer

por Warth, Arne, Muley, Thomas, Meister, Michael, Herpel, Esther, Pathil, Anita, Hoffmann, Hans, Schnabel, Philipp A, Bender, Christian, Buness, Andreas, Schirmacher, Peter, Kuner, Ruprecht
Publicado 2011

Prognostic Impact of CT-Quantified Muscle and Fat Distribution before and after First-Line-Chemotherapy in Lung Cancer Patients

por Nattenmüller, Johanna, Wochner, Raoul, Muley, Thomas, Steins, Martin, Hummler, Simone, Teucher, Birgit, Wiskemann, Joachim, Kauczor, Hans-Ulrich, Wielpütz, Mark Oliver, Heussel, Claus Peter
Publicado 2017

FAM83A and FAM83B as Prognostic Biomarkers and Potential New Therapeutic Targets in NSCLC

por Richtmann, Sarah, Wilkens, Dennis, Warth, Arne, Lasitschka, Felix, Winter, Hauke, Christopoulos, Petros, Herth, Felix J. F., Muley, Thomas, Meister, Michael, Schneider, Marc A.
Publicado 2019